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CD69 is a widespread receptor of the immune system cells. Although a physiological 
ligand for this receptor is still unknown, in Laboratory of protein architecture its affinity towards a 
range of compounds including calcium, carbohydrates and charged compounds such as 
carboxylated calixarenes, has been proved. Moreover, a pentapeptide sequence LELTE derived 
from a mycobacterial chaperonine protein hsp65 has been recently identified as a ligand for CD69 
representing a "danger" signal for the immune system. However, this peptide is not immunoactive 
per se, but only after its presentation within the multivalent environment of its parent protein, or 
after artificial dimerization using bi- or polyfunctional reagents. 
In this thesis I evaluate for four newly synthesized compounds their in vitro immunological 
effects on cellular signalization, proliferation, natural killing of tumors and on induction of 
apoptotic cell death in immunocytes. The tested compounds present LELTE peptide through 
attachment to a cyclopeptidic RAFT scaffold (K-K-K-P-G)2 through the ε-amino groups of lysine 
residues, alone or in combination with a carbohydrate α-GalNAc epitope. The ability of such 
scaffolds to activate human PBMC lymphocytes is enhanced in compounds, which possess both 
peptide and carbohydrate ligands. Moreover, all compounds are inactive from the point of view of 
activation-induced apoptosis of lymphocytes. However, triggering of CD69 by compounds 
containing only LELTE sequences inhibited natural killing in vitro. The activation abilities make 
the combined peptide / carbohydrate RAFT glycoconjugates suitable for evaluation in experimental 
animal tumor therapies in vivo. 
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